NU(NU)
NU
Q3 2026 EPS Estimate
$0.20
Aug 13, 2026 · Reports after close
Revenue Estimate
$5.39B
FY2026E EPS$0.84
FY2027E EPS$1.11
Analyst Sentiment
Wall St. Consensus
Hold22 analysts·High coverage
61
Score
12 Buy (55%)8 Hold (36%)2 Sell (9%)
Rating Breakdown
Strong Buy
00%
Buy
1255%
Hold
836%
Sell
29%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$13.00
-1.2%
Consensus
$14.95
+13.6%
Bull
$17.00
+29.2%
12-Month Target Range22 analysts
$13.00$14.95$17.00
Current $13.16Consensus
Current Price
$13.16
Upside to Consensus
$1.79
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+22.64%
EPS+31.70%
FY2028
Rev+12.83%
EPS+29.36%
FY2029
Rev+0.86%
EPS+23.18%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $22.15B | $27.16B | $30.65B | $30.91B |
| Low | $21.18B | $24.11B | $28.14B | $28.38B |
| High | $22.87B | $30.48B | $33.44B | $33.73B |
| EBITDA Avg | $7.16B | $8.78B | $9.91B | $9.99B |
| Low | $6.85B | $7.80B | $9.10B | $9.17B |
| High | $7.39B | $9.85B | $10.81B | $10.91B |
| EBIT Avg | $2.28B | $2.80B | $3.16B | $3.19B |
| Low | $2.18B | $2.49B | $2.90B | $2.93B |
| High | $2.36B | $3.14B | $3.45B | $3.48B |
| Net Income Avg | $4.02B | $5.32B | $7.06B | $8.70B |
| Low | $3.60B | $4.37B | $5.78B | $7.77B |
| High | $4.44B | $6.17B | $8.81B | $9.73B |
| EPS Avg | $0.84 | $1.11 | $1.44 | $1.77 |
| Low | $0.73 | $0.89 | $1.18 | $1.58 |
| High | $0.91 | $1.26 | $1.80 | $1.98 |
| Analysts (Rev / EPS) | 5 / 11 | 7 / 11 | 3 / 11 | 2 / 4 |
Quarterly
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $5.39B | $5.58B | $5.81B | $5.83B | $6.24B | $6.53B | $6.83B | $6.42B |
| Low | $5.37B | $5.28B | $5.53B | $5.55B | $5.95B | $6.22B | $6.51B | $6.12B |
| High | $5.41B | $5.81B | $6.02B | $6.04B | $6.47B | $6.77B | $7.09B | $6.67B |
| EBITDA Avg | $1.74B | $1.80B | $1.88B | $1.88B | $2.02B | $2.11B | $2.21B | $2.08B |
| Low | $1.74B | $1.71B | $1.79B | $1.79B | $1.92B | $2.01B | $2.10B | $1.98B |
| High | $1.75B | $1.88B | $1.95B | $1.95B | $2.09B | $2.19B | $2.29B | $2.16B |
| EBIT Avg | $555M | $575M | $598M | $600M | $643M | $673M | $704M | $662M |
| Low | $553M | $545M | $570M | $572M | $613M | $641M | $671M | $631M |
| High | $558M | $599M | $621M | $623M | $667M | $698M | $730M | $687M |
| Net Income Avg | $1.01B | $1.08B | $1.20B | $1.25B | $1.37B | $1.44B | $1.57B | $1.47B |
| Low | $957M | $1.01B | $1.12B | $1.17B | $1.29B | $1.35B | $1.48B | $1.38B |
| High | $1.06B | $1.13B | $1.26B | $1.31B | $1.44B | $1.51B | $1.65B | $1.55B |
| EPS Avg | $0.21 | $0.22 | $0.24 | $0.25 | $0.28 | $0.29 | $0.32 | $0.30 |
| Low | $0.19 | $0.21 | $0.23 | $0.24 | $0.26 | $0.27 | $0.30 | $0.28 |
| High | $0.22 | $0.23 | $0.26 | $0.27 | $0.29 | $0.31 | $0.34 | $0.31 |
| Analysts (Rev / EPS) | 3 / 6 | 3 / 5 | 2 / 1 | 1 / 1 | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 2 |